{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:42:50Z","timestamp":1794649370426,"version":"4.9.1"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Trauma Acute Care Surg"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>The use of tranexamic acid in trauma patients at risk for hemorrhage remains controversial. This guideline evaluates the use of tranexamic acid in two clinical settings, the prehospital environment and the inpatient setting. In addition, this PMG evaluates the use TXA in specific populations and at different dosages and evaluates the potential risks associated with its use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Using the Grading of Recommendations Assessment, Development and Evaluation methodology, an EAST working group conducted a systematic review using MEDLINE, EMBASE, and COCHRANE CENTRAL. Articles in English from 2000 through 2023 were considered in evaluating four PICO questions relevant to the use of TXA in injured trauma patients at risk of hemorrhage (defined as patients with a systolic blood pressure (SBP) \u226490 mm Hg or a heart rate \u2265110\/min or suspicion for active hemorrhage).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Thirty studies were identified for qualitative analysis, of which 24 met criteria for meta-analysis. TXA was associated with a significant reduction in 24-hour mortality in both prehospital (log risk ratio, \u22120.29; 95% confidence interval, \u22120.53 to \u22120.05;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.02) and in-hospital settings (\u22120.38[\u22120.69, \u22120.06];\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.02). A similar benefit was observed at 30-days across both settings (prehospital: \u22120.18[\u22120.35, \u22120.00];\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.05, in-hospital: \u22120.24[\u22120.40, \u22120.07];\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.01). In patients with SBP \u226475 mm Hg, TXA reduced mortality, but this was not found to be significant (\u22120.18 [\u22120.46, 0.09];\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.20). The incidence of vaso-occlusive events did not differ between groups in either setting. Moreover, a large heterogeneity regarding TXA dosing regimens and comparison groups across studies was observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Based on current available evidence, we conditionally recommend for the routine use of TXA in the prehospital and in-hospital settings. We cannot recommend for or against the use of an initial higher dose of bolus TXA. Finally, we conditionally recommend for the routine use of TXA in patients with severe hypotension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LEVEL OF EVIDENCE<\/jats:title>\n                    <jats:p>Systematic Review\/Meta-Analyses; Level III.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ta.0000000000004773","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T15:00:24Z","timestamp":1758034824000},"page":"785-794","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["The use of tranexamic acid in the management of injured patients at risk of hemorrhage: a systematic review and meta-analysis and an Eastern Association for the Surgery of Trauma Practice Management Guideline"],"prefix":"10.1097","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6566-1833","authenticated-orcid":false,"given":"Ryan P.","family":"Dumas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahaa E.","family":"Succar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Vella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel D.","family":"Appelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda A.","family":"Dultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushal H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimitt J.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra M.","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy Z.","family":"Kornblith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick B.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany K.","family":"Bankhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Sleet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Molavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofya H.","family":"Asfaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin A.","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew E.","family":"Kutcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason L.","family":"Sperry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy W.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"issue":"2","key":"bib1-20260128","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/ejh.13348","article-title":"The many roles of tranexamic acid: an overview of the clinical indications for TXA in medical and surgical patients","volume":"104","year":"2020","journal-title":"Eur J Haematol"},{"issue":"Suppl 1","key":"bib2-20260128","first-page":"50","article-title":"The current place of tranexamic acid in the management of bleeding","volume":"70","year":"2015","journal-title":"Anaesthesia"},{"issue":"4","key":"bib3-20260128","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJM199807233390407","article-title":"Hemostatic drugs","volume":"339","journal-title":"N Engl J Med"},{"issue":"6","key":"bib4-20260128","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/MOH.0000000000000084","article-title":"Adjunct agents for bleeding","volume":"21","year":"2014","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"bib5-20260128","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/SLA.0000000000000717","article-title":"Tranexamic acid use in severely injured civilian patients and the effects on outcomes: a prospective cohort study","volume":"261","year":"2015","journal-title":"Ann Surg"},{"issue":"2","key":"bib6-20260128","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa2215457","article-title":"Prehospital tranexamic acid for severe trauma","volume":"389","year":"2023","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"bib7-20260128","first-page":"11","article-title":"Tranexamic acid during prehospital transport in patients at risk for hemorrhage after injury: a double-blind, placebo-controlled, Randomized Clinical Trial","volume":"156","year":"2020","journal-title":"JAMA Surg"},{"issue":"2","key":"bib8-20260128","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archsurg.2011.287","article-title":"Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study","volume":"147","year":"2012","journal-title":"Arch Surg"},{"issue":"9734","key":"bib9-20260128","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","year":"2010","journal-title":"Lancet"},{"key":"bib10-20260128","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/S0140-6736(16)00433-5","article-title":"Effect of early tranexamic acid on the coagulation system in patients with suspected traumatic haemorrhage: a prospective cohort study","volume":"387","year":"2016","journal-title":"The Lancet"},{"issue":"4","key":"bib11-20260128","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/TA.0000000000001613","article-title":"Military use of tranexamic acid in combat trauma: does it matter?","volume":"83","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"issue":"3","key":"bib12-20260128","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/TA.0000000000001333","article-title":"Damage control resuscitation in patients with severe traumatic hemorrhage: a practice management guideline from the Eastern Association for the Surgery of Trauma","volume":"82","year":"2017","journal-title":"J Trauma Scute Care Surg"},{"issue":"7650","key":"bib13-20260128","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"bib14-20260128","doi-asserted-by":"crossref","first-page":"e000107","DOI":"10.1136\/tsaco-2017-000107","article-title":"Antifibrinolytics in a rural trauma state: assessing the opportunities","volume":"2","year":"2017","journal-title":"Trauma Surg Acute Care Open"},{"key":"bib15-20260128","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jss.2018.07.074","article-title":"Prehospital tranexamic acid administration during aeromedical transport after injury","volume":"233","year":"2019","journal-title":"J Surg Res"},{"issue":"3","key":"bib16-20260128","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/JTN.0000000000000437","article-title":"A retrospective study of transfusion requirements in trauma patients receiving tranexamic acid","volume":"26","year":"2019","journal-title":"J Trauma Nurs"},{"issue":"6","key":"bib17-20260128","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.amjsurg.2019.10.004","article-title":"Does tranexamic acid really work in an urban US level I trauma center? A single level 1 trauma center's experience","volume":"218","year":"2019","journal-title":"Am J Surg"},{"issue":"2","key":"bib18-20260128","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ajem.2019.04.051","article-title":"Prehospital administration of tranexamic acid in trauma patients: a 1:1 matched comparative study from a level 1 trauma center","volume":"38","year":"2020","journal-title":"Am J Emerg Med"},{"issue":"1","key":"bib19-20260128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00068-023-02262-4","article-title":"Pre-hospital tranexamic acid administration in patients with a severe hemorrhage: an evaluation after the implementation of tranexamic acid administration in the Dutch pre-hospital protocol","volume":"50","year":"2024","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"2","key":"bib20-20260128","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/IJCIIS.IJCIIS_79_20","article-title":"Safety and efficacy of thromboelastography guidance of antifibrinolytic therapy in trauma patients: an observational cohort analysis","volume":"11","year":"2021","journal-title":"Int J Crit Illn Inj Sci"},{"issue":"1","key":"bib21-20260128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13054-021-03701-7","article-title":"The impact of prehospital tranexamic acid on mortality and transfusion requirements: match-pair analysis from the nationwide German TraumaRegister DGU\u00ae","volume":"25","year":"2021","journal-title":"Crit Care"},{"issue":"4","key":"bib22-20260128","article-title":"Effects of tranexamic acid on mortality and blood transfusion in trauma patients with significant hemorrhage: a clinical trial","volume":"5","year":"2017","journal-title":"Advances in Bioscience and Clinical Medicine"},{"issue":"5","key":"bib23-20260128","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/TA.0000000000002022","article-title":"Severely injured trauma patients with admission hyperfibrinolysis: is there a role of tranexamic acid? Findings from the PROPPR trial","volume":"85","year":"2018","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"bib24-20260128","first-page":"115","article-title":"Administration of tranexamic acid in trauma patients under stricter inclusion criteria increases the treatment window for stabilization from 24 to 48 hours-a retrospective review","volume":"7","year":"2017","journal-title":"Int J Burns Trauma"},{"key":"bib25-20260128","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jss.2017.04.028","article-title":"Tranexamic acid is associated with increased mortality in patients with physiological fibrinolysis","volume":"220","year":"2017","journal-title":"J Surg Res"},{"issue":"3","key":"bib26-20260128","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/jamasurg.2013.764","article-title":"Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study","volume":"148","year":"2013","journal-title":"JAMA Surg"},{"issue":"1","key":"bib27-20260128","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/TA.0000000000002061","article-title":"Tranexamic acid administration is associated with an increased risk of posttraumatic venous thromboembolism","volume":"86","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"bib28-20260128","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5811\/westjem.2019.10.43055","article-title":"Safety and efficacy of hospital utilization of tranexamic acid in civilian adult trauma resuscitation","volume":"21","year":"2020","journal-title":"West J Emerg Med"},{"issue":"6","key":"bib29-20260128","doi-asserted-by":"crossref","first-page":"977","DOI":"10.5811\/westjem.2018.8.39336","article-title":"Tranexamic acid in civilian trauma care in the California Prehospital Antifibrinolytic Therapy Study","volume":"19","year":"2018","journal-title":"West J Emerg Med"},{"issue":"4","key":"bib30-20260128","first-page":"E958","article-title":"The effect of early tranexamic acid on bleeding, blood product consumption, mortality and length of hospital stay in trauma cases with hemorrhagic shock: a randomized clinical trial","volume":"62","year":"2021","journal-title":"J Prev Med Hyg"},{"issue":"1","key":"bib31-20260128","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/SHK.0000000000001608","article-title":"Is tranexamic acid associated with mortality or multiple organ failure following severe injury?","volume":"55","year":"2021","journal-title":"Shock"},{"issue":"1","key":"bib32-20260128","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/MBC.0000000000000983","article-title":"The incidence of venous thromboembolic events in trauma patients after tranexamic acid administration: an EAST multicenter study","volume":"32","year":"2021","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"6","key":"bib33-20260128","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/bjs.10497","article-title":"Effectiveness of early administration of tranexamic acid in patients with severe trauma","volume":"104","year":"2017","journal-title":"Br J Surg"},{"key":"bib34-20260128","first-page":"2085","article-title":"The immunologic effect of Early intravenous two and four gram bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding (TAMPITI): a randomized, double-blind, placebo-controlled","volume":"11","year":"2020","journal-title":"Single-Center Trial Front Immunol"},{"key":"bib35-20260128","article-title":"Tranexamic acid use in trauma: effective but not without consequences","year":"2013","journal-title":"J Trauma Treat"},{"issue":"6","key":"bib36-20260128","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/TA.0000000000000242","article-title":"Do all trauma patients benefit from tranexamic acid?","volume":"76","year":"2014","journal-title":"J Trauma Acute Care Surg"},{"issue":"8","key":"bib37-20260128","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1007\/s00268-021-06143-y","article-title":"Does liberal prehospital and in-hospital tranexamic acid influence outcome in severely injured patients? A prospective cohort study","volume":"45","year":"2021","journal-title":"World J Surg"},{"issue":"1","key":"bib38-20260128","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13054-016-1322-5","article-title":"Prehospital administration of tranexamic acid in trauma patients","volume":"20","year":"2016","journal-title":"Crit Care"},{"issue":"1","key":"bib39-20260128","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12874-020-0897-3","article-title":"Software tools to support title and abstract screening for systematic reviews in healthcare: an evaluation","volume":"20","year":"2020","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"bib40-20260128","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"10116","key":"bib41-20260128","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(17)32455-8","article-title":"Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40\u2008138 bleeding patients","volume":"391","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"bib42-20260128","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jtha.2023.10.001","article-title":"When to use tranexamic acid for the treatment of major bleeding?","volume":"22","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"2","key":"bib43-20260128","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/emermed-2018-207693","article-title":"Implementation of tranexamic acid for bleeding trauma patients: a longitudinal and cross-sectional study","volume":"36","year":"2019","journal-title":"Emerg Med J"},{"issue":"1","key":"bib44-20260128","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40560-023-00661-8","article-title":"Prehospital tranexamic acid for trauma victims","volume":"11","year":"2023","journal-title":"J Intensive Care"},{"issue":"1","key":"bib45-20260128","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13063-016-1750-1","article-title":"Tranexamic acid in bleeding trauma patients: an exploration of benefits and harms","volume":"18","year":"2017","journal-title":"Trials"},{"issue":"3","key":"bib46-20260128","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1213\/ANE.0000000000004234","article-title":"Fibrinolysis shutdown in trauma: historical review and clinical implications","volume":"129","year":"2019","journal-title":"Anesth Analg"},{"issue":"10","key":"bib47-20260128","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.2020.8958","article-title":"Effect of out-of-hospital tranexamic acid vs placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury","volume":"324","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"bib48-20260128","doi-asserted-by":"crossref","first-page":"36","DOI":"10.55460\/ZWV3-5CBW","article-title":"The use of tranexamic acid in tactical combat casualty care: TCCC proposed change 20-02","volume":"20","year":"2020","journal-title":"J Spec Oper Med"},{"key":"bib49-20260128","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.seizure.2016.02.011","article-title":"Tranexamic acid-associated seizures: a meta-analysis","volume":"36","year":"2016","journal-title":"Seizure"}],"container-title":["Journal of Trauma and Acute Care Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000004773","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:00:55Z","timestamp":1769630455000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000004773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ta.0000000000004773","relation":{},"ISSN":["2163-0763","2163-0755"],"issn-type":[{"value":"2163-0763","type":"electronic"},{"value":"2163-0755","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"assertion":[{"value":"2025-05-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}